L‐arginine vs placebo
L‐arginine showed no clear difference in frequency of crisis (monthly crisis) compared with placebo (low certainty).
- RR 0.71 [0.26, 1.95]1 study · 50 participantsLow
L‐arginine showed no clear difference in frequency of crisis (monthly crisis) compared with placebo (low certainty).
L‐arginine showed no clear difference in severity of pain (assessed using a 10‐cm visual analogue scale from… compared with placebo (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether L‐arginine changes frequency of hospitalization (number of days in hospital) compared with placebo (very low certainty).
The review found no eligible studies for this question.
L‐arginine showed no clear difference in haemoglobin status (g/dL) compared with placebo (low certainty).
Glyceryl trinitrate (GTN) showed no clear difference in death or dependency (mRS>2), end of trial (90 days) compared with no GTN (high certainty).
Glyceryl trinitrate (GTN) showed no clear difference in death, end of trial (90 days) compared with no GTN (high certainty).
Glyceryl trinitrate (GTN) leads to higher adverse event: Headache, on treatment (7‐12 days) compared with no GTN (high certainty).